Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review.
about
Refractory adult-onset Still disease complicated by macrophage activation syndrome and acute myocarditis: A case report treated with high doses (8 mg/kg/d) of anakinraSuccessful Treatment with Intravenous Cyclophosphamide for Refractory Adult-Onset Still's Disease.Adult-Onset Still's Disease: Still a Serious Health Problem (a Case Report and Literature Review).Treatment of adult-onset still's disease: up to date.Response to Interleukin-1 Inhibitors in 140 Italian Patients with Adult-Onset Still's Disease: A Multicentre Retrospective Observational Study.Interleukin-1 Blockade: An Update on Emerging Indications.[Still's disease in children and adults].[Efficacy and safety analysis of off-label treatment with biologics in autoinflammatory diseases : Experiences from a German registry (GRAID2)].A retrospective study of patients with adult-onset Still's disease: is pericarditis a possible predictor for biological disease-modifying anti-rheumatic drugs need?A Pilot Study on Tocilizumab for Treating Refractory Adult-Onset Still's Disease.Biologic drugs in adult onset Still's disease: a systematic review and meta-analysis of observational studies.Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease.Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.Diagnostic and management of life-threatening Adult-Onset Still Disease: a French nationwide multicenter study and systematic literature review.
P2860
Q33817997-32728F9D-1A90-4656-8582-A776D26AC613Q36427179-14286647-06EE-47C2-8A7C-5A52FDA07483Q37636502-F9E394A3-245E-4EDE-8C01-805F28F942ECQ38679486-73BA95CF-1FA0-4757-8C45-B45EB3DB33BEQ38703626-AC9088DC-9083-4CBA-A41F-5E892DF843D5Q39301613-93BD45F9-2818-40B5-AE84-FFDC101CB33BQ40045645-1EAA7D55-4446-43E4-9A17-8C87B3C9FAF0Q40053587-8AAF5CE3-11D8-4FFC-BB24-6C915D4F2B6EQ40116554-4DA03A4B-0248-427C-BD4D-E28CA266C482Q42677427-1014B70A-B389-4BAD-AA40-F05607A03637Q50224636-33E3CDEF-0FC7-49C6-9993-69B4E712EC5DQ51748695-E3B43B90-5E6A-4564-A8B5-662C77F08923Q52642372-8F26CEAE-E8E5-489A-A4CC-A0014539DEF7Q55109011-627FBFDD-3297-4B04-A2A8-BDD795C2EDC5
P2860
Efficacy of Anakinra in Refractory Adult-Onset Still's Disease: Multicenter Study of 41 Patients and Literature Review.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Efficacy of Anakinra in Refrac ...... atients and Literature Review.
@ast
Efficacy of Anakinra in Refrac ...... atients and Literature Review.
@en
type
label
Efficacy of Anakinra in Refrac ...... atients and Literature Review.
@ast
Efficacy of Anakinra in Refrac ...... atients and Literature Review.
@en
prefLabel
Efficacy of Anakinra in Refrac ...... atients and Literature Review.
@ast
Efficacy of Anakinra in Refrac ...... atients and Literature Review.
@en
P2093
P2860
P50
P1433
P1476
Efficacy of Anakinra in Refrac ...... Patients and Literature Review
@en
P2093
Alejandro Olivé
Anne Riveros
Carmen Ordóñez
Catalina Gómez-Arango
Eva Galíndez-Agirregoikoa
Francisco Ortiz-Sanjuán
Inmaculada Jiménez-Moleón
Javier Llorca
Javier Loricera
Jordi Fiter
P2860
P356
10.1097/MD.0000000000001554
P407
P50
P577
2015-09-01T00:00:00Z